1.Characteristics of traditional Chinese medicine pattern distribution of metabolic syndrome based on latent class analysis and latent structure analysis
AXINBAI MALINA ; Yidian YANG ; Huan ZHANG ; Yuqing ZHAO ; Liping ZHANG
Journal of Beijing University of Traditional Chinese Medicine 2024;47(4):532-544
Objective To analyze the distribution of traditional Chinese medicine patterns in metabolic syndrome(MS),with the aim of deriving the attributes and characteristics of patterns in patients with MS more accurately and finely.Methods The data of 695 MS patients admitted to Dongfang Hospital,Beijing University of Chinese Medicine from December 2017 to September 2022 were retrospectively analyzed to derive traditional Chinese medicine patterns using latent class analysis and latent structure analysis,and the above results were used to identify the pattern type of each patient according to differentiation of syndromes,to determine the traditional Chinese medicine pattern types of MS patients.Results A total of 9,044 times of the symptoms and signs were included in this study,and the top 10 high-frequency symptoms and signs were dry mouth and polydipsia(77.70%),fatigue(60.58%),greasy fur(59.14%),blurred vision(54.68%),slippery pulse(53.96%),wiry pulse(52.09%),white fur(48.92%),numbness of the limbs(43.60%),yellow fur(39.71%),and cold limbs(36.40%).Based on the result of the latent class analysis,this study determined the main pattern elements of 695 patients with MS.The pathological pattern elements included qi deficiency,phlegm-dampness,dampness-heat,qi stagnation,yin deficiency,fire-heat,and impairment of body fluids;the pathological pattern elements were mainly located in liver,spleen,lung,and kidney;the 695 patients could be classified into three main groups:predominantly deficiency syndrome,predominantly excess syndrome,and deficiency syndrome accompanied with excess syndrome.Through analyzing the latent structure model of the symptoms and signs of 695 patients with MS,six basic syndromes were established,which were the syndromes of hyperactivity of liver yang,deficiency in the spleen with dampness retention,deficiency of both kidney yin and yang,consumption of body fluids due to intense heat,blood stasis due to qi deficiency,and stagnation of liver qi with stomach heat.Combined with the theory of Chinese medicine,the four-diagnosis information of 695 cases of MS was comprehensively integrated,and on the basis of latent class analysis and latent structure analysis,secondary syndrome differentiation of patients was performed.A total of 20 syndromes with a frequency of occurrence of>1%were finally obtained,with the highest frequency being the syndrome of stagnation of liver qi and spleen deficiency,internal retention of dampness-heat(12.66%).Conclusion The pathogenesis of MS is complex and the pattern types are widely distributed,but in general,the syndrome of stagnation of liver qi and spleen deficiency,and internal retention of dampness-heat is the most common.Therefore,clinically,based on syndrome differentiation and treatment,attention should be paid to combining the application of invigorating the spleen and soothing the liver,and clearing heat to resolve turbidity.
2.Efficacy analysis of the radiotherapy and chemotherapy in patients with stage Ⅳ esophageal squamous carcinoma: a multicenter retrospective study of Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG R-01F)
Miaomiao HU ; Qianqian YUAN ; Xusheng ZHANG ; Sen YANG ; Xin WANG ; Lan WANG ; Junqiang CHEN ; Wencheng ZHANG ; Xiaomin WANG ; Xiaolin GE ; Wenbin SHEN ; Yonggang XU ; Chongli HAO ; Zhiguo ZHOU ; Shuai QIE ; Na LU ; Qingsong PANG ; Yidian ZHAO ; Xinchen SUN ; Gaofeng LI ; Ling LI ; Xueying QIAO ; Miaoling LIU ; Yadi WANG ; Chen LI ; Shuchai ZHU ; Chun HAN ; Kaixian ZHANG ; Zefen XIAO
Chinese Journal of Oncology 2020;42(8):676-681
Objective:To evaluate the survival and prognostic factors of radiotherapy in patient with Ⅳ stage esophageal squamous carcinoma treated with radiation or chemoradiation.Methods:The medical records of 608 patients with stage Ⅳ esophageal squamous cell carcinoma who met the inclusion criteria in 10 medical centers in China from 2002 to 2016 were retrospectively analyzed. The overall survival and prognostic factors of all patients at 1, 3 and 5 years were analyzed.Results:The 1-, 3-, 5- year overall survival (OS) rates was 66.7%, 29.5% and 24.3% in stage ⅣA patients, and 58.8%, 29.0% and 23.5% in stage ⅣB patients. There was no statistical difference between the two groups ( P=0.255). Univariate analysis demonstrated that the length of lesion, treatment plan, planned tumor target volume (PGTV) dose, subsequent chemotherapy, and degrees of anemia, radiation esophagitis, radiation pneumonia were related to the prognoses of patients with Ⅳ stage esophageal carcinomas after radiotherapy and chemotherapy ( P<0.05). Multivariate analysis demonstrated that PGTV dose ( OR=0.693, P=0.004), radiation esophagitis ( OR=0.867, P=0.038), and radiation pneumonia ( OR=1.181, P=0.004) were independent prognostic factors for OS. Conclusions:For patients with stage Ⅳ esophageal squamous cell carcinoma, chemoradiotherapy followed by sequential chemotherapy is recommended, which can extend the total survival and improve the prognosis of the patients. PGTV dose more than 60 Gy has better efficacy.
3.Efficacy analysis of the radiotherapy and chemotherapy in patients with stage Ⅳ esophageal squamous carcinoma: a multicenter retrospective study of Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG R-01F)
Miaomiao HU ; Qianqian YUAN ; Xusheng ZHANG ; Sen YANG ; Xin WANG ; Lan WANG ; Junqiang CHEN ; Wencheng ZHANG ; Xiaomin WANG ; Xiaolin GE ; Wenbin SHEN ; Yonggang XU ; Chongli HAO ; Zhiguo ZHOU ; Shuai QIE ; Na LU ; Qingsong PANG ; Yidian ZHAO ; Xinchen SUN ; Gaofeng LI ; Ling LI ; Xueying QIAO ; Miaoling LIU ; Yadi WANG ; Chen LI ; Shuchai ZHU ; Chun HAN ; Kaixian ZHANG ; Zefen XIAO
Chinese Journal of Oncology 2020;42(8):676-681
Objective:To evaluate the survival and prognostic factors of radiotherapy in patient with Ⅳ stage esophageal squamous carcinoma treated with radiation or chemoradiation.Methods:The medical records of 608 patients with stage Ⅳ esophageal squamous cell carcinoma who met the inclusion criteria in 10 medical centers in China from 2002 to 2016 were retrospectively analyzed. The overall survival and prognostic factors of all patients at 1, 3 and 5 years were analyzed.Results:The 1-, 3-, 5- year overall survival (OS) rates was 66.7%, 29.5% and 24.3% in stage ⅣA patients, and 58.8%, 29.0% and 23.5% in stage ⅣB patients. There was no statistical difference between the two groups ( P=0.255). Univariate analysis demonstrated that the length of lesion, treatment plan, planned tumor target volume (PGTV) dose, subsequent chemotherapy, and degrees of anemia, radiation esophagitis, radiation pneumonia were related to the prognoses of patients with Ⅳ stage esophageal carcinomas after radiotherapy and chemotherapy ( P<0.05). Multivariate analysis demonstrated that PGTV dose ( OR=0.693, P=0.004), radiation esophagitis ( OR=0.867, P=0.038), and radiation pneumonia ( OR=1.181, P=0.004) were independent prognostic factors for OS. Conclusions:For patients with stage Ⅳ esophageal squamous cell carcinoma, chemoradiotherapy followed by sequential chemotherapy is recommended, which can extend the total survival and improve the prognosis of the patients. PGTV dose more than 60 Gy has better efficacy.